These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
862 related articles for article (PubMed ID: 21951942)
1. The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: systematic reviews registry database analyses and economic evaluation. Robertson C; Arcot Ragupathy SK; Boachie C; Dixon JM; Fraser C; Hernández R; Heys S; Jack W; Kerr GR; Lawrence G; MacLennan G; Maxwell A; McGregor J; Mowatt G; Pinder S; Ternent L; Thomas RE; Vale L; Wilson R; Zhu S; Gilbert FJ Health Technol Assess; 2011 Sep; 15(34):v-vi, 1-322. PubMed ID: 21951942 [TBL] [Abstract][Full Text] [Related]
2. Testing strategies for Lynch syndrome in people with endometrial cancer: systematic reviews and economic evaluation. Stinton C; Jordan M; Fraser H; Auguste P; Court R; Al-Khudairy L; Madan J; Grammatopoulos D; Taylor-Phillips S Health Technol Assess; 2021 Jun; 25(42):1-216. PubMed ID: 34169821 [TBL] [Abstract][Full Text] [Related]
3. Supplemental Screening as an Adjunct to Mammography for Breast Cancer Screening in People With Dense Breasts: A Health Technology Assessment. Ontario Health (Quality) Ont Health Technol Assess Ser; 2023; 23(9):1-293. PubMed ID: 39364436 [TBL] [Abstract][Full Text] [Related]
4. Surveillance mammography for detecting ipsilateral breast tumour recurrence and metachronous contralateral breast cancer: a systematic review. Robertson C; Ragupathy SK; Boachie C; Fraser C; Heys SD; Maclennan G; Mowatt G; Thomas RE; Gilbert FJ; Eur Radiol; 2011 Dec; 21(12):2484-91. PubMed ID: 21833567 [TBL] [Abstract][Full Text] [Related]
5. Systematic review and modelling of the cost-effectiveness of cardiac magnetic resonance imaging compared with current existing testing pathways in ischaemic cardiomyopathy. Campbell F; Thokala P; Uttley LC; Sutton A; Sutton AJ; Al-Mohammad A; Thomas SM Health Technol Assess; 2014 Sep; 18(59):1-120. PubMed ID: 25265259 [TBL] [Abstract][Full Text] [Related]
6. Cancer screening with digital mammography for women at average risk for breast cancer, magnetic resonance imaging (MRI) for women at high risk: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2010; 10(3):1-55. PubMed ID: 23074406 [TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography/computerised tomography imaging in detecting and managing recurrent cervical cancer: systematic review of evidence, elicitation of subjective probabilities and economic modelling. Meads C; Auguste P; Davenport C; Małysiak S; Sundar S; Kowalska M; Zapalska A; Guest P; Thangaratinam S; Martin-Hirsch P; Borowiack E; Barton P; Roberts T; Khan K Health Technol Assess; 2013 Mar; 17(12):1-323. PubMed ID: 23537558 [TBL] [Abstract][Full Text] [Related]
8. The INTRABEAM® Photon Radiotherapy System for the adjuvant treatment of early breast cancer: a systematic review and economic evaluation. Picot J; Copley V; Colquitt JL; Kalita N; Hartwell D; Bryant J Health Technol Assess; 2015 Aug; 19(69):1-190. PubMed ID: 26323045 [TBL] [Abstract][Full Text] [Related]
9. Optimal surveillance strategies for patients with stage 1 cutaneous melanoma post primary tumour excision: three systematic reviews and an economic model. Vale L; Kunonga P; Coughlan D; Kontogiannis V; Astin M; Beyer F; Richmond C; Wilson D; Bajwa D; Javanbakht M; Bryant A; Akor W; Craig D; Lovat P; Labus M; Nasr B; Cunliffe T; Hinde H; Shawgi M; Saleh D; Royle P; Steward P; Lucas R; Ellis R Health Technol Assess; 2021 Nov; 25(64):1-178. PubMed ID: 34792018 [TBL] [Abstract][Full Text] [Related]
10. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501 [TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation. Cooper KL; Meng Y; Harnan S; Ward SE; Fitzgerald P; Papaioannou D; Wyld L; Ingram C; Wilkinson ID; Lorenz E Health Technol Assess; 2011 Jan; 15(4):iii-iv, 1-134. PubMed ID: 21276372 [TBL] [Abstract][Full Text] [Related]
12. Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis. Harnan S; Tappenden P; Cooper K; Stevens J; Bessey A; Rafia R; Ward S; Wong R; Stein RC; Brown J Health Technol Assess; 2019 Jun; 23(30):1-328. PubMed ID: 31264581 [TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy. Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170 [TBL] [Abstract][Full Text] [Related]
14. Elucigene FH20 and LIPOchip for the diagnosis of familial hypercholesterolaemia: a systematic review and economic evaluation. Sharma P; Boyers D; Boachie C; Stewart F; Miedzybrodzka Z; Simpson W; Kilonzo M; McNamee P; Mowatt G Health Technol Assess; 2012; 16(17):1-266. PubMed ID: 22469073 [TBL] [Abstract][Full Text] [Related]
15. Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis. Westwood M; Joore M; Grutters J; Redekop K; Armstrong N; Lee K; Gloy V; Raatz H; Misso K; Severens J; Kleijnen J Health Technol Assess; 2013 Apr; 17(16):1-243. PubMed ID: 23611316 [TBL] [Abstract][Full Text] [Related]
16. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer. Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100 [TBL] [Abstract][Full Text] [Related]
17. Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost-effectiveness model. Sutcliffe P; Connock M; Pulikottil-Jacob R; Kandala NB; Suri G; Gurung T; Grove A; Shyangdan D; Briscoe S; Maheswaran H; Clarke A Health Technol Assess; 2013 Nov; 17(53):1-499, v-vi. PubMed ID: 24280231 [TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk. Geuzinge HA; Obdeijn IM; Rutgers EJT; Saadatmand S; Mann RM; Oosterwijk JC; Tollenaar RAEM; de Roy van Zuidewijn DBW; Lobbes MBI; van 't Riet M; Hooning MJ; Ausems MGEM; Loo CE; Wesseling J; Luiten EJT; Zonderland HM; Verhoef C; Heijnsdijk EAM; Tilanus-Linthorst MMA; de Koning HJ; JAMA Oncol; 2020 Sep; 6(9):1381-1389. PubMed ID: 32729887 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study. Duffy SW; Mackay J; Thomas S; Anderson E; Chen TH; Ellis I; Evans G; Fielder H; Fox R; Gui G; Macmillan D; Moss S; Rogers C; Sibbering M; Wallis M; Warren R; Watson E; Whynes D; Allgood P; Caunt J Health Technol Assess; 2013 Mar; 17(11):vii-xiv, 1-95. PubMed ID: 23489892 [TBL] [Abstract][Full Text] [Related]